Cargando…
Genetic and epigenetic factors determining NAFLD risk
BACKGROUND: Hepatic steatosis is a common chronic liver disease that can progress into more severe stages of NAFLD or promote the development of life-threatening secondary diseases for some of those affected. These include the liver itself (nonalcoholic steatohepatitis or NASH; fibrosis and cirrhosi...
Autores principales: | Jonas, Wenke, Schürmann, Annette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324682/ https://www.ncbi.nlm.nih.gov/pubmed/33160101 http://dx.doi.org/10.1016/j.molmet.2020.101111 |
Ejemplares similares
-
Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk
por: Dabravolski, Siarhei A., et al.
Publicado: (2021) -
Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Del Campo, José A, et al.
Publicado: (2018) -
PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?
por: Theys, Claudia, et al.
Publicado: (2022) -
Genetics Is of the Essence to Face NAFLD
por: Meroni, Marica, et al.
Publicado: (2021) -
Epigenetic contribution to obesity
por: Ouni, Meriem, et al.
Publicado: (2020)